Cepheid Inc. - Company & Market Research Reports

Home /
Companies /
Cepheid Inc.

Cepheid is an American molecular diagnostics company that develops, manufactures and markets fully integrated systems for testing in the clinical market, and for application in its original non-clinical market. The company's systems enable rapid, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid was founded in March 1996 and is headquartered in Sunnyvale, California.

REFINE BY

KEYWORD

2025 Europe Molecular Diagnostics Market in 38 Countries: 2024 Supplier Shares, Analyzer Installed Base and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

 Report
March 2025
Europe

From

€12364EUR$13,500USD£10,532GBP

2025 Asia-Pacific Molecular Diagnostics Market in 18 Countries: 2024 Supplier Shares, Analyzer Installed Base and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

 Report
March 2025
Asia Pacific

From

€8700EUR$9,500USD£7,412GBP

2025 World Molecular Diagnostics Market in 92 Countries: 2024 Supplier Shares, Analyzer Installed Base and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

 Report
March 2025
Global

From

€22438EUR$24,500USD£19,114GBP

Cardiovascular Surgery Devices and Equipment Market Report 2025

 Report
April 2025
250 Pages
Global

From

€4112EUR$4,490USD£3,503GBP

Enteric Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
May 2024
184 Pages
Global

From

€4121EUR$4,500USD£3,511GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

STD Testing Device Market Report: Trends, Forecast and Competitive Analysis to 2031

 Report
March 2025
150 Pages
Global

From

€4442EUR$4,850USD£3,784GBP

COVID-19 Detection Test Kits and Consumables Market Report 2025

 Report
April 2025
250 Pages
Global

From

€4112EUR$4,490USD£3,503GBP

Tuberculosis Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
188 Pages
Global

From

€4121EUR$4,500USD£3,511GBP

Home Diagnostics Market: Strategies and Trends - Forecasts by Application, by Channel, by Technology and by Country, with Market Analysis and Executive Guides

 Report
May 2025
392 Pages
Global

From

€6406EUR$6,995USD£5,457GBP

Companion Diagnostics Market Report 2025

 Report
January 2025
200 Pages
Global

From

€4112EUR$4,490USD£3,503GBP

Chlamydia Infection Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

 Report
April 2023
112 Pages
Global

From

€4350EUR$4,750USD£3,706GBP

Oncology Based Molecular Diagnostic Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
July 2024
92 Pages
Global

From

€3500EUR$4,094USD£3,086GBP

Oncology Molecular Diagnostics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
July 2024
92 Pages
Global

From

€3500EUR$4,094USD£3,086GBP

Infectious Disease Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€3434EUR$3,750USD£2,926GBP

2024 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
430 Pages
United States

From

€2519EUR$2,750USD£2,145GBP

2024 UK Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
408 Pages
United Kingdom

From

€2519EUR$2,750USD£2,145GBP

2024 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
407 Pages
Spain

From

€2519EUR$2,750USD£2,145GBP

2024 Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
402 Pages
Italy

From

€2519EUR$2,750USD£2,145GBP

2024 Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
407 Pages
Germany

From

€2519EUR$2,750USD£2,145GBP

2024 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
407 Pages
France

From

€2519EUR$2,750USD£2,145GBP

900 Results (Page 14 of 45)
- 1
- 12
- 13
- 14
- 15
- 16

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.